Hwa An Medical Obtains U.S. Patent for Diabetic Ulcer Treatment Method

1. Date of Event: August 10, 115

2. Company Name: Hwa An Medical Co., Ltd.

3. Relationship to Company:本公司 (Our Company)

4. Cross-shareholding Ratio: Not applicable

5. Reason for Occurrence: Our company has filed a patent application with the United States Patent and Trademark Office for the method of treating diabetic ulcers titled 'Use of adenine in preparation of drug for treating diabetic ulcers,' application number 18/279,108, which has now been reviewed and approved.

6. Response Measures: Not applicable

7. Other Matters to be Disclosed: (1) With the acquisition of this patent, the patent protection for F703DFU is expected to extend until March 25, 131, which will support international licensing activities. (2) New drug development involves long timelines, high investment costs, and does not guarantee success, potentially exposing investors to risks. Investors are advised to make careful and informed decisions.